Search results
BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial
Clinical Trials Arena via Yahoo Finance· 1 day agoThe 925 participants in the open-label ...inhibitor. It has been approved to treat a variety of...
Benefit for Warner Cox set for May 11
Rome Sentinel· 4 days agoThere will be a benefit for Warner Cox from noon to 4 p.m. Saturday, May 11 at the Remsen VFW, located at 10526 Steuben St. Cox is battling stage
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 4 hours agoA Phase 3 study is already underway with the initial results expected later this decade. But at...
Just Say No to Drugs: 3 Pharma Stocks to Avoid
InvestorPlace via Yahoo Finance· 6 days agoYear-to-date, the S&P Biotechnology Select Industry Index has dropped by 4%. Likewise, the number of biotech firms shrunk by 3% in 2023. Although...
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks via Yahoo Finance· 1 day agoBristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails...
US County-Level Study Shows Benefits of PSA Screening
Medscape· 5 days agoA recent analysis found that US counties with higher rates of PSA screening had lower rates of...
Q2 2024 EPS Estimates for Janux Therapeutics, Inc. Cut by William Blair (NASDAQ:JANX)
ETF DAILY NEWS· 5 days agoJanux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Stock analysts at William Blair reduced their Q2 2024 earnings estimates for shares of Janux Therapeutics in a research note issued on ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoPomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT) and certain officers. The class action ...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against...
Morningstar· 2 days agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of HireRight Holdings Corporation ...
